A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
Investigate the safety and tolerability, as well as PK profile of ceftazidime-avibactam (CAZ -AVI) administered in single and repeated intravenous (IV) infusions in healthy Chinese subjects.This study data will be used to support CAZ-AVI NDA in China.
Epistemonikos ID: c12505da033b118fc8271b7106398c24d5d3d101
First added on: May 11, 2024